M. Bayliss

发表

Predicting conserved essential genes in bacteria: in silico identification of putative drug targets.

I. Cooper, P. Oyston, M. Duffield, 2010, Molecular bioSystems.

Antibody-mediated protection against MERS-CoV in the murine model☆

S. Weller, E. Williamson, N. Almond, 2019, Vaccine.

Virus-like particles as a novel platform for delivery of protective Burkholderia antigens

M. Bayliss, 2016 .

Dual route vaccination for plague with emergency use applications.

E. Williamson, B. D. Moore, J. Steward, 2018, Vaccine.

Purification and biochemical characterisation of GlmU from Yersinia pestis

D. Mengin-Lecreulx, D. Patin, D. Blanot, 2015, Archives of Microbiology.

Assessments of hepatitis B virus-like particles and Crm197 as carrier proteins in melioidosis glycoconjugate vaccines

R. Field, S. Nepogodiev, N. Harmer, 2020, bioRxiv.

Structural characterisation of the capsular polysaccharide expressed by Burkholderia thailandensis strain E555:: wbiI (pKnock-KmR) and assessment of the significance of the 2-O-acetyl group in immune protection

R. Field, S. Nepogodiev, N. Harmer, 2017, Carbohydrate research.

Dose–response analysis of Bacillus thuringiensis HD‐1 cry‐ spore reduction on surfaces using formaldehyde with pre‐germination

N. Govan, M. Bayliss, D. Payne, 2022, Journal of applied microbiology.

Efficacy of finafloxacin in a murine model of inhalational glanders

T. Laws, A. Vente, M. Bayliss, 2022, Frontiers in Microbiology.

Purification and biochemical characterisation of GlmU from Yersinia pestis

D. Mengin-Lecreulx, D. Patin, D. Blanot, 2015, Archives of Microbiology.